The sixth ESMO Asia Congress will be completely virtual and will be taking place from the 20 - 22 November 2020
Download the ESMO Asia Virtual Congress 2020 Industry Guidelines
This exciting landmark event will bring together oncologists from the region and beyond to present the latest discoveries in medical oncology.
A renowned scientific committee comprising leading Asian and European experts has developed an extensive programme comprising 14 tracks, which will address new developments in the respective field as well as updating delegates on the latest standards of care across all major tumour types. The congress will be an important forum for sponsors to engage with Asian prescribers and to present their latest products as well as services in a brand new virtual congress environment!
ESMO gratefully acknowledges the valuable contribution of the following organisations in the ESMO Asia Congresses over the years.
- AbbVie Pte Ltd
- Accord Healthcare
- ACT Genomics
- Asia Genomics
- Astellas Pharma Inc.
- Bayer HealthCare Pharmaceuticals, Inc.
- Beacon Medicare Limited
- Boehringer Ingelheim Singapore Pte. Ltd.
- Bristol-Myers Squibb
- Cancer Expert Now
- Caris Life Sciences
- Clearbridge Health
- Eisai Co. Ltd
- F. Hoffman-La Roche Ltd
- Ferring Pharmaceuticals
- Fresenius Kabi Deutschland GmbH
- Guardant Health
- Human Longevity, Inc.
- Human Metabolome Technologies
- Invivoscribe, Inc
- Lilly Oncology
- Lucence Diagnostics
- Medscape Oncology
- Merck Pfizer Alliance
- MSD Pharma (Singapore) Pte Ltd
- Myriad Genetics
- NanoString Technologies
- Pierre Fabre
- Quark Biosciences
- Sanofi-Aventis Singapore Pte Ltd
- Singapore Precision Medicine Centre Pte Ltd.
- Sysmex Asia Pacific
- Takeda Pharmaceuticals
- Tessa Therapeutics Pte Ltd
- Thermo Fisher Scientifc
- Xi'an Good Doctor Medical Science and Technology Co. Ltd.
- Zai Lab (Hong Kong) Limited
How can I participate in ESMO Asia Virtual Congress 2020?
Contact the ESMO Asia Events Sponsorship Team for more details and we look forward to hearing from you!